China's Covid Strategy

Ian discusses the ineffectiveness of China's zero Covid strategy in the face of the more transmissible Omicron variant, highlighting the lack of natural immunity among the population and poor vaccine options. Meanwhile, he expresses optimism about the pandemic's trajectory in the West, noting that better therapeutics and public demand for normalcy are paving the way for a transition to an endemic phase. However, the ongoing trade reliance on China poses significant supply chain challenges moving forward.